{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:53:54Z","timestamp":1781830434157,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82402149"],"award-info":[{"award-number":["82402149"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32130040"],"award-info":[{"award-number":["32130040"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515110053"],"award-info":[{"award-number":["2021A1515110053"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20220818100806015"],"award-info":[{"award-number":["JCYJ20220818100806015"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["JCYJ20210324101402007"],"award-info":[{"award-number":["JCYJ20210324101402007"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M713283"],"award-info":[{"award-number":["2022M713283"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA0912400"],"award-info":[{"award-number":["2022YFA0912400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ymthe.2026.01.032","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T15:42:21Z","timestamp":1769701341000},"page":"2678-2691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tumor cell AMPK activation enhances NK cell anti-tumor immunity and synergizes with PD-L1 blockade therapy"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9521-1630","authenticated-orcid":false,"given":"Zhen","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houjun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9695-6757","authenticated-orcid":false,"given":"Youhai H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.01.032_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad7118","article-title":"PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations","volume":"8","author":"Zou","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.01.032_bib2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental Mechanisms of Immune Checkpoint Blockade Therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2026.01.032_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","article-title":"Harnessing innate immunity in cancer therapy","volume":"574","author":"Olivier","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.01.032_bib4","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","article-title":"A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments","volume":"24","author":"Barry","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2026.01.032_bib5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ni.3518","article-title":"Targeting natural killer cells in cancer immunotherapy","volume":"17","author":"Guillerey","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.032_bib6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.032_bib7","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1172\/JCI99317","article-title":"Contribution of NK cells to immunotherapy mediated by PD-1\/PD-L1 blockade","volume":"128","author":"Hsu","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.01.032_bib8","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1158\/2159-8290.CD-18-1259","article-title":"The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector","volume":"9","author":"Dong","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2026.01.032_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav7816","article-title":"Sensitization to immune checkpoint blockade through activation of a STAT1\/NK axis in the tumor microenvironment","volume":"11","author":"Zemek","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymthe.2026.01.032_bib10","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1158\/0008-5472.CAN-19-0617","article-title":"Microenvironmental Metabolism Regulates Antitumor Immunity","volume":"79","author":"Ngwa","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.01.032_bib11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40425-019-0627-8","article-title":"Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNgamma receptor signaling","volume":"7","author":"Marijt","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.01.032_bib12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the 'missing self': MHC molecules and NK cell recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol. Today"},{"key":"10.1016\/j.ymthe.2026.01.032_bib13","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2026.01.032_bib14","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1128\/MCB.00166-06","article-title":"5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments","volume":"26","author":"Laderoute","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymthe.2026.01.032_bib15","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI29044","article-title":"AMP-activated protein kinase signaling in metabolic regulation","volume":"116","author":"Long","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.01.032_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrm3311","article-title":"AMPK: a nutrient and energy sensor that maintains energy homeostasis","volume":"13","author":"Hardie","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.01.032_bib17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1101\/sqb.2011.76.010819","article-title":"Adenosine Monophosphate-Activated Protein Kinase: A Central Regulator of Metabolism with Roles in Diabetes, Cancer, and Viral Infection","volume":"76","author":"Hardie","year":"2011","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.ymthe.2026.01.032_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/fon.09.174","article-title":"AMPK as a metabolic tumor suppressor: control of metabolism and cell growth","volume":"6","author":"Luo","year":"2010","journal-title":"Future Oncol."},{"key":"10.1016\/j.ymthe.2026.01.032_bib19","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1158\/0008-5472.CAN-12-3876","article-title":"AMPK: a contextual oncogene or tumor suppressor?","volume":"73","author":"Liang","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.01.032_bib20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.canlet.2014.01.018","article-title":"The AMP-activated protein kinase (AMPK) and cancer: Many faces of a metabolic regulator","volume":"356","author":"Faubert","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2026.01.032_bib21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tips.2015.11.007","article-title":"Evolving Lessons on the Complex Role of AMPK in Normal Physiology and Cancer","volume":"37","author":"Dasgupta","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymthe.2026.01.032_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2021.08.011","article-title":"STK11\/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?","volume":"157","author":"Di Federico","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ymthe.2026.01.032_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009444","article-title":"LKB1 dictates sensitivity to immunotherapy through Skp2-mediated ubiquitination of PD-L1 protein in non-small cell lung cancer","volume":"12","author":"Lv","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.ymthe.2026.01.032_bib24","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.01.032_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/icb.2013.96","article-title":"Cell biological steps and checkpoints in accessing NK cell cytotoxicity","volume":"92","author":"Mace","year":"2014","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.01.032_bib26","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.immuni.2010.09.016","article-title":"Intravital Imaging Reveals Distinct Dynamics for Natural Killer and CD8+ T Cells during Tumor Regression","volume":"33","author":"Deguine","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.01.032_bib27","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.4049\/jimmunol.173.5.3357","article-title":"NK Cells Use Perforin Rather than Granulysin for Anticryptococcal Activity","volume":"173","author":"Ma","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.032_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/j.gastro.2008.04.022","article-title":"Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer","volume":"135","author":"Rhee","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymthe.2026.01.032_bib29","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1158\/0008-5472.CAN-12-2027","article-title":"Role of chemokines and chemokine receptors in shaping the effector phase of the antitumor immune response","volume":"72","author":"Franciszkiewicz","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2026.01.032_bib30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2018.09.016","article-title":"Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response","volume":"49","author":"Marcus","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.01.032_bib31","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1126\/science.1200094","article-title":"AMPK is a direct adenylate charge-regulated protein kinase","volume":"332","author":"Oakhill","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.01.032_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature09932","article-title":"Structure of mammalian AMPK and its regulation by ADP","volume":"472","author":"Xiao","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.01.032_bib33","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1042\/bj3380717","article-title":"AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge","volume":"338","author":"Hardie","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymthe.2026.01.032_bib34","doi-asserted-by":"crossref","first-page":"27952","DOI":"10.1074\/jbc.M109.046292","article-title":"AMP-activated protein kinase mediates the interferon-gamma-induced decrease in intestinal epithelial barrier function","volume":"284","author":"Scharl","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymthe.2026.01.032_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.77","article-title":"Targeted apoptosis in ovarian cancer cells through mitochondrial dysfunction in response to Sambucus nigra agglutinin","volume":"8","author":"Chowdhury","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ymthe.2026.01.032_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.630166","article-title":"Granule Leakage Induces Cell-Intrinsic, Granzyme B-Mediated Apoptosis in Mast Cells","volume":"9","author":"Burgener","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymthe.2026.01.032_bib37","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ymthe.2026.01.032_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033411","article-title":"Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis","volume":"7","author":"Noto","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2026.01.032_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/aje\/kwu124","article-title":"Reduced Risk of Lung Cancer With Metformin Therapy in Diabetic Patients: A Systematic Review and Meta-Analysis","volume":"180","author":"Zhang","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ymthe.2026.01.032_bib40","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/srep00362","article-title":"Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells","volume":"2","author":"Song","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.01.032_bib41","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/bjc.2013.187","article-title":"Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK","volume":"108","author":"Storozhuk","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymthe.2026.01.032_bib42","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1073\/pnas.1417636112","article-title":"Immune-mediated antitumor effect by type 2 diabetes drug, metformin","volume":"112","author":"Eikawa","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.01.032_bib43","article-title":"Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk","volume":"6","author":"Peng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2026.01.032_bib44","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.molcel.2018.07.030","article-title":"Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1","volume":"71","author":"Cha","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ymthe.2026.01.032_bib45","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10549-011-1612-1","article-title":"Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial","volume":"128","author":"Hadad","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ymthe.2026.01.032_bib46","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13058-015-0598-8","article-title":"Metformin in breast cancer - an evolving mystery","volume":"17","author":"Camacho","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ymthe.2026.01.032_bib47","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10549-015-3307-5","article-title":"Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial","volume":"150","author":"M","year":"2015","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162600033X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162600033X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:31:58Z","timestamp":1781829118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162600033X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S152500162600033X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.032","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor cell AMPK activation enhances NK cell anti-tumor immunity and synergizes with PD-L1 blockade therapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}